E. Ohman J or Asset Management AB Increases Stock Position in Agilent Technologies, Inc. $A

E. Ohman J or Asset Management AB boosted its holdings in Agilent Technologies, Inc. (NYSE:A) by 38.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,870 shares of the medical research company’s stock after acquiring an additional 3,850 shares during the quarter. E. Ohman J or Asset Management AB’s holdings in Agilent Technologies were worth $1,842,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in A. Fiduciary Trust Co increased its holdings in shares of Agilent Technologies by 1.6% in the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after purchasing an additional 77 shares in the last quarter. Freestone Capital Holdings LLC lifted its holdings in shares of Agilent Technologies by 2.0% during the fourth quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock valued at $574,000 after purchasing an additional 84 shares in the last quarter. Sapient Capital LLC lifted its holdings in shares of Agilent Technologies by 4.2% during the first quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock valued at $240,000 after purchasing an additional 85 shares in the last quarter. Plan A Wealth LLC boosted its position in shares of Agilent Technologies by 3.2% during the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock valued at $403,000 after buying an additional 92 shares during the last quarter. Finally, IHT Wealth Management LLC boosted its position in shares of Agilent Technologies by 4.9% during the fourth quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock valued at $278,000 after buying an additional 96 shares during the last quarter.

Agilent Technologies Stock Performance

Shares of A opened at $149.31 on Wednesday. The firm has a market capitalization of $42.17 billion, a P/E ratio of 29.98, a PEG ratio of 2.64 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27. The business has a fifty day moving average of $134.70 and a 200 day moving average of $125.23.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. The company had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.Agilent Technologies’s revenue was up 10.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 6.01 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were paid a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is 20.48%.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Jefferies Financial Group initiated coverage on Agilent Technologies in a research report on Thursday, July 9th. They issued a “hold” rating and a $135.00 target price for the company. Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their price target for the company from $150.00 to $145.00 in a report on Thursday, May 28th. Wells Fargo & Company reduced their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. Royal Bank Of Canada began coverage on shares of Agilent Technologies in a research note on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price target for the company. Finally, Wolfe Research restated a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, Agilent Technologies has a consensus rating of “Moderate Buy” and an average price target of $159.35.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.